NAD injections: the complete guide (2026)

Key takeaways

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell that declines 40-60% between ages 40 and 60
NAD injections bypass the gut and liver, delivering the molecule directly into subcutaneous tissue for faster absorption
IV NAD+ drips take 2-4 hours and cost $500-1,500 per session; subcutaneous injections take under a minute and cost $50-150
Typical injection doses range from 100-500 mg administered subcutaneously, with most protocols starting at 100-200 mg
Human clinical trial data on injectable NAD+ remains limited, though NAD+ precursor trials show consistent safety profiles
NAD injections require a prescription from a licensed provider and should be sourced from regulated compounding pharmacies

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell. It exists in two forms: NAD+ (oxidized) and NADH (reduced). Together, they shuttle electrons between metabolic reactions, making them indispensable for converting food into energy [1].

Beyond energy metabolism, NAD+ is a substrate for three enzyme families that regulate cellular health: sirtuins (which control gene expression and DNA repair), PARPs (which fix damaged DNA), and CD38 (which regulates immune signaling) [2]. When NAD+ levels drop, all three systems slow down.

The problem is that NAD+ levels decline with age. A 2021 review in Nature Reviews Molecular Cell Biology documented that tissue NAD+ concentrations fall substantially during middle age, driven by increased consumption from CD38 and decreased synthesis [1]. This decline correlates with many age-related conditions, though whether it causes them directly or simply accompanies them is still being worked out.

NAD injections aim to restore these levels by delivering the molecule directly into tissue, bypassing the digestive system entirely. This distinguishes them from oral NAD+ precursors like NMN and NR, which must be absorbed through the gut and converted through enzymatic steps before becoming active NAD+ [3].

How NAD injections work

When you take NAD+ by mouth, it faces a gauntlet. Stomach acid, intestinal enzymes, and first-pass liver metabolism all break it down before it reaches systemic circulation. That is why most oral NAD+ supplements use precursors (NMN or NR) instead of NAD+ itself.

NAD injections skip that process. Administered subcutaneously (under the skin) or intramuscularly, the NAD+ molecule enters tissue directly and is absorbed into the bloodstream without hepatic first-pass metabolism. Subcutaneous injections create a depot effect, releasing NAD+ gradually over several hours.

The pharmacokinetics differ from IV infusions. An IV NAD+ drip delivers a large dose (250-1,000 mg) directly into the bloodstream over 2-4 hours, creating a sharp spike in blood NAD+ levels. Subcutaneous injections produce a more gradual rise, with lower peak concentrations but potentially more sustained tissue exposure.

One important distinction: when we talk about “NAD injections,” we mean injections of the NAD+ molecule itself, not its precursors. Some clinics offer injectable NMN or NAD+ in various formulations. The protocols discussed here focus on direct NAD+ administration through subcutaneous injection.

NAD injections vs IV drips vs oral supplements

Each delivery method has tradeoffs in bioavailability, convenience, cost, and evidence base.

IV NAD+ infusions deliver the highest single-session dose (250-1,000 mg) directly into the bloodstream. They require a clinical setting, IV placement, and 2-4 hours of sitting time. Many patients report discomfort during infusion, including chest tightness, nausea, and cramping. Sessions typically cost $500-1,500 each.

Subcutaneous NAD+ injections use smaller doses (100-500 mg) that patients can self-administer at home after proper training. The injection takes under a minute. Absorption is slower than IV but faster and more direct than oral delivery. Sessions cost $50-150 per injection when prescribed through a compounding pharmacy.

Oral NAD+ precursors (NMN and NR) are the most studied delivery method. Multiple randomized controlled trials have confirmed that oral NMN raises blood NAD+ levels by 40-60% in healthy adults [4, 5]. However, the molecule must survive digestion and undergo enzymatic conversion, which introduces variability. A 2023 multicenter trial of 80 healthy adults found that NMN at 300-900 mg/day safely increased blood NAD+ levels in a dose-dependent manner [6]. Monthly costs range from $30-100 for supplements.

For a detailed breakdown of how these precursors compare, see our guide on NAD+ vs NMN vs NR.

Who uses NAD injections

NAD injection therapy attracts several distinct groups:

Adults over 40 concerned about age-related decline. NAD+ levels drop significantly during middle age [1]. Some adults use NAD injections as part of a broader longevity protocol alongside exercise, diet, and other interventions. The theory is straightforward: restore declining NAD+ to support cellular repair mechanisms. The evidence is promising but still building. Our guide on NAD+ for anti-aging covers the longevity research in detail.

People experiencing chronic fatigue. Because NAD+ is central to mitochondrial energy production, some patients with persistent fatigue explore NAD therapy. The logic tracks with basic biochemistry, but controlled human trials specifically measuring fatigue outcomes with injectable NAD+ are not yet available.

Athletes and fitness enthusiasts. NAD+ supports mitochondrial function and cellular energy metabolism. Some athletes use NAD injections for recovery, though the evidence base here relies primarily on the known biochemistry rather than sports-specific clinical trials.

People seeking cognitive support. A 2023 study in Neuron demonstrated that NAD+ supplementation rescued age-related blood-brain barrier damage in animal models [7]. A separate trial found that oral NR raised NAD+ and lowered biomarkers of neurodegenerative pathology in human plasma [8]. These findings fuel interest in NAD therapy for brain health, though injectable NAD+ has not been specifically tested for cognitive outcomes in humans.

Post-addiction recovery. Some clinics have used IV NAD+ infusions as part of substance abuse detox protocols for decades, though published clinical trial data supporting this use is limited. Subcutaneous injections are sometimes offered as a more accessible continuation protocol.

Benefits of NAD injections

The benefits of NAD injections stem from restoring a molecule that declines with age and fuels hundreds of enzymatic reactions.

Cellular energy production. NAD+ is required for mitochondrial electron transport, the final step in converting food to ATP. Low NAD+ means less efficient energy production at the cellular level [1].

DNA repair support. Both PARP enzymes and sirtuins require NAD+ as a substrate. PARPs consume NAD+ during DNA repair, while sirtuins (particularly SIRT1 and SIRT6) regulate gene expression related to stress resistance and longevity [2, 9]. A 2020 study in Scientific Reports showed that extracellular NAD+ enhanced PARP-dependent DNA repair independently of other pathways [10].

Sirtuin activation. The seven mammalian sirtuins depend on NAD+ to function. When NAD+ levels are adequate, sirtuins deacetylate proteins involved in inflammation, metabolism, and cellular stress responses. When NAD+ drops, sirtuin activity falls proportionally [2, 11].

Faster absorption than oral supplements. By skipping the digestive system, NAD injections avoid the enzymatic degradation that oral NAD+ faces. While oral precursors like NMN do raise blood NAD+ effectively [5], direct injection delivers the molecule itself without requiring conversion steps.

For the full evidence breakdown, see our guide on NAD injection benefits.

Side effects and safety

NAD injections are generally well-tolerated at standard doses, but they are not side-effect-free. Common reactions include:

Injection site redness, swelling, or mild pain (the most frequent complaint)
Nausea, particularly at higher doses (300+ mg)
Flushing and warmth
Lightheadedness
Abdominal cramping

These effects are typically dose-dependent. Starting at lower doses (100 mg) and titrating up reduces their frequency and intensity. IV NAD+ infusions tend to produce more pronounced side effects than subcutaneous injections because of the rapid blood level spike.

The safety profile of NAD+ precursors in clinical trials is reassuring. A 2023 review in Advances in Nutrition analyzed multiple human trials of NMN supplementation and found no serious adverse events across doses up to 1,250 mg/day [4]. A 2024 study of long-term NMN supplementation in Japanese men confirmed safety over 12 months [12]. A randomized trial of NR in obese men found it was safe and well-tolerated [13].

For direct injectable NAD+, the published safety data is more limited. Most safety evidence comes from clinical experience in IV NAD+ therapy settings, where thousands of infusions have been administered without serious adverse events reported in the literature.

Read our full safety breakdown at NAD injection side effects.

Dosage and administration

NAD injection dosing protocols vary by provider, but most follow a general framework:

Starting dose: 50-100 mg subcutaneously, to assess tolerance.

Maintenance dose: 100-250 mg, 2-3 times per week during a loading phase, then 1-2 times per week for maintenance.

Upper range: Some protocols use 500 mg per injection, though higher doses increase the likelihood of side effects.

Administration route: Most NAD injections are given subcutaneously in the abdomen, thigh, or upper arm. Intramuscular injection is an alternative. The subcutaneous route is preferred for self-administration because it is simpler and less painful.

Injection technique: NAD+ is typically supplied as a sterile solution in a multi-dose vial. Patients use an insulin syringe, inject into a pinched fold of skin at a 45-degree angle, and rotate injection sites. If you are new to self-injection, our guides on how to inject peptides and peptide injection sites cover the fundamentals.

The optimal dose and frequency depend on individual factors including age, baseline NAD+ status, and treatment goals. A provider should determine the appropriate protocol based on your health history.

Research and clinical evidence

The science behind NAD+ therapy comes from three tiers of evidence, and it is worth being transparent about where each stands.

Tier 1: Established biochemistry. NAD+ is central to energy metabolism, DNA repair, and sirtuin signaling. This is settled science supported by thousands of studies. The 2021 Nature Reviews paper by Covarrubias et al. is the definitive review [1].

Tier 2: NAD+ precursor human trials. Multiple randomized controlled trials show that oral NMN and NR safely raise blood NAD+ levels in humans. A 2023 multicenter RCT found NMN supplementation (300-900 mg/day) increased blood NAD+ in a dose-dependent manner in 80 healthy adults [6]. A 2024 study confirmed long-term NMN safety over 12 months [12]. A meta-analysis of NMN trials found benefits for muscle and liver function markers [14].

Tier 3: Injectable NAD+ in humans. This is where the evidence thins out. Published controlled trials of injectable (subcutaneous or intramuscular) NAD+ in humans are scarce. The clinical rationale rests on the strong preclinical and precursor data combined with the pharmacokinetic advantage of bypassing first-pass metabolism. Clinics offering NAD injections draw on decades of clinical experience with IV NAD+ therapy, but the peer-reviewed evidence for subcutaneous injection specifically is still early.

This gap matters. The science supporting NAD+ as a molecule is strong. The science supporting the specific injection delivery method is based more on clinical experience and pharmacological reasoning than on randomized trials.

How to get NAD injections

NAD injections are a prescription therapy. Here is how the process typically works:

Medical consultation. A licensed provider evaluates your health history, goals, and any contraindications. Many patients access this through telehealth NAD therapy platforms.
Prescription. If appropriate, the provider writes a prescription for NAD+ injectable solution, specifying concentration and volume.
Compounding pharmacy. The prescription is filled by a compounding pharmacy that prepares sterile NAD+ solution according to USP standards. Using a 503A or 503B pharmacy ensures quality and sterility.
Self-administration. After training, most patients self-inject at home. The injection is subcutaneous and straightforward.
Follow-up. Providers typically check in after 4-6 weeks to assess response and adjust dosing.

For information on pricing, see our NAD injection cost guide. If you are interested in getting started, Pure Peptide Clinic connects you with licensed providers who can determine if NAD therapy is appropriate for your situation.

Frequently asked questions

How long do NAD injection effects last?▼

Most patients report effects from a single injection lasting 1-3 days. This is why maintenance protocols call for 2-3 injections per week during loading and 1-2 per week for ongoing use. Individual responses vary based on age, metabolism, and baseline NAD+ status.

Are NAD injections better than NAD+ supplements?▼

They deliver NAD+ by different mechanisms. Injections provide the molecule directly, while supplements use precursors (NMN or NR) that the body converts to NAD+. Oral NMN has been shown to raise blood NAD+ by 40-60% in clinical trials [5, 6]. Injections bypass digestion entirely. Neither approach has definitive long-term outcome data showing one is superior to the other.

Do NAD injections hurt?▼

Most patients describe the injection itself as a brief pinch. Some NAD+ formulations cause a mild burning or stinging sensation at the injection site that fades within minutes. Using proper technique and rotating sites minimizes discomfort. See our guide on how to inject peptides for best practices.

How quickly do NAD injections work?▼

Some patients report increased energy and mental clarity within hours of their first injection. Others notice gradual improvements over 1-2 weeks of consistent use. There is no standardized timeline because individual responses depend on baseline NAD+ depletion and other factors.

Can I take NAD injections with other peptide therapies?▼

Many patients combine NAD therapy with other peptide protocols. Common combinations include NAD+ with BPC-157 for recovery support or with CJC-1295/Ipamorelin for growth hormone optimization. A provider should evaluate your full protocol for potential interactions.

Do I need a prescription for NAD injections?▼

Yes. Injectable NAD+ is a prescription medication in the United States. It must be prescribed by a licensed provider and dispensed by a compounding pharmacy. You cannot legally purchase injectable NAD+ without a prescription. Learn more about how to get peptides prescribed.

How much do NAD injections cost?▼

Individual NAD injections typically cost $50-150 each when sourced from a compounding pharmacy. This is significantly less than IV NAD+ drips, which run $500-1,500 per session. Monthly costs depend on injection frequency. See our NAD injection cost guide for a full breakdown.

Are NAD injections FDA-approved?▼

NAD+ injections are not FDA-approved as a standalone drug. They are available through compounding pharmacies under the oversight of a prescribing provider. This is the same regulatory pathway used for many compounding pharmacy peptides. The NAD+ molecule itself is a naturally occurring coenzyme, not a novel pharmaceutical.

References

Covarrubias AJ, Perrone R, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141. PubMed
Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-471. PubMed
Yoshino J, Baur JA, Imai S. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metab. 2018;27(3):513-528. PubMed
Song Q, Zhou X, et al. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. Adv Nutr. 2023;14(6):1416-1435. PubMed
Irie J, et al. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects. Front Nutr. 2022;9:868640. PubMed
Yi L, Maier AB, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Geroscience. 2023;45(1):29-43. PubMed
NAD+ rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis. Neuron. 2023;111(22):3634-3649. PubMed
Vreones M, Mustapic M, et al. Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin. Aging Cell. 2023;22(1):e13754. PubMed
Chini CCS, Cordeiro HS, et al. NAD metabolism: Role in senescence regulation and aging. Aging Cell. 2024;23(1):e13920. PubMed
Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity. Sci Rep. 2020;10(1):651. PubMed
Guarente L, Sinclair DA, et al. Human trials exploring anti-aging medicines. Cell Metab. 2024;36(2):354-376. PubMed
Yamaguchi S, Irie J, et al. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men. Endocr J. 2024;71(2):153-169. PubMed
Dollerup OL, Christensen B, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018;108(2):343-353. PubMed
Wang JP, Wang L, et al. Effects of Nicotinamide Mononucleotide Supplementation on Muscle and Liver Functions Among the Middle-aged and Elderly: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Curr Pharm Biotechnol. 2025;26(1):40-51. PubMed